2015
DOI: 10.1016/j.mrgentox.2014.11.002
|View full text |Cite
|
Sign up to set email alerts
|

Histone markers identify the mode of action for compounds positive in the TK6 micronucleus assay

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
25
1

Year Published

2016
2016
2019
2019

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 21 publications
(27 citation statements)
references
References 29 publications
1
25
1
Order By: Relevance
“…γH2AX is a biomarker of DNA double strand breaks that appears to be applicable to in vitro genotoxicity testing strategies [Audebert et al, ; Smart et al, ; Garcia‐Canton et al, ; Nikolova et al, ]. As several previous reports have suggested, when γH2AX readings are coupled with mitotic cell (phospho‐histone H3‐positive event) readings, additional information is gained that is useful for discriminating between clastogenic and aneugenic activities [Bryce et al, ; Cheung et al, Khoury et al, ].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…γH2AX is a biomarker of DNA double strand breaks that appears to be applicable to in vitro genotoxicity testing strategies [Audebert et al, ; Smart et al, ; Garcia‐Canton et al, ; Nikolova et al, ]. As several previous reports have suggested, when γH2AX readings are coupled with mitotic cell (phospho‐histone H3‐positive event) readings, additional information is gained that is useful for discriminating between clastogenic and aneugenic activities [Bryce et al, ; Cheung et al, Khoury et al, ].…”
Section: Introductionmentioning
confidence: 99%
“…Test Aneugen; Aurora B kinase inhibitor; clastogenic properties reported at high concentrations that are attributed to topoisomerase II inhibition Olaharski et al, 2005;Gollapudi et al, 2014 Flubendazole gH2AX is a biomarker of DNA double strand breaks that appears to be applicable to in vitro genotoxicity testing strategies [Audebert et al, 2010;Smart et al, 2011;Garcia-Canton et al, 2013;Nikolova et al, 2014]. As several previous reports have suggested, when gH2AX readings are coupled with mitotic cell (phospho-histone H3-positive event) readings, additional information is gained that is useful for discriminating between clastogenic and aneugenic activities [Bryce et al, 2014;Cheung et al, 2015Khoury et al, 2015.…”
Section: Introductionmentioning
confidence: 99%
“…These goals explain recent efforts to develop higher information content genotoxicity assays that are amenable to rapid, automatic data acquisition platforms. Diverse approaches have been investigated, and include automation of conventional genotoxicity endpoints [Avlasevich et al, 2006;Rossnerova et al, 2011], identification of toxicogenomic signatures [Li et al, 2015], use of stably transfected cells with reporters for GADD45a, p53, or other DNA damage signaling pathways [Yang and Duerksen-Hughes, 1998;Hendriks et al, 2012;Walmsley and Tate, 2012], and use of various phenotype-based biomarkers of genotoxicity, for example induction of hypo-/ hyperdiploidy in mitotic cells [Muehlbauer and Schuler, 2005;Muehlbauer et al, 2008], or gH2AX [Audebert et al, 2010;Smart et al, 2011;Garcia-Canton et al, 2013;Nikolova et al, 2014;Cheung et al, 2015].…”
mentioning
confidence: 99%
“…The flow cytometric MN assay (MicroFlow ® ) was considered positive if a ≥3‐fold increase in MN frequency was observed compared to the solvent control [Bryce et al, ]. Our findings revealed that two genotoxic compounds (H 2 O 2 and BP) were judged inconclusive and three nongenotoxicants (CCCP, TG, and TC) were tested positive and therefore represented the frequently misleading positives in the MNT due to secondary effects [Walmsley and Billinton, ; Bryce et al, ; Cheung et al, ]. For these studies, cytotoxicity measurements were based on RNC that has been shown to underestimate cytotoxicity compared to relative population doubling (RPD) or relative increase in cell count (RICC) [Fellows et al, ; Galloway et al, ].…”
Section: Discussionmentioning
confidence: 80%